CIR_AACR Profile Banner
Cancer Immunology Research Profile
Cancer Immunology Research

@CIR_AACR

Followers
4K
Following
192
Media
3K
Statuses
4K

Follow Cancer Immunology Research for outstanding research across the cancer immunology discipline, accelerating effective immunotherapies. Published by @AACR.

Joined July 2018
Don't wanna be here? Send us removal request.
@CIR_AACR
Cancer Immunology Research
30 days
The June issue is online
Tweet media one
1
0
3
@CIR_AACR
Cancer Immunology Research
1 day
What We're Reading: Article Recommendations from Our Deputy and Senior Editors
Tweet media one
1
0
6
@CIR_AACR
Cancer Immunology Research
1 day
The July issue is online.
Tweet media one
0
0
6
@CIR_AACR
Cancer Immunology Research
3 days
In Situ Delivery of Gasdermin E mRNA Promotes Antitumor Immunity via Creatine-Elicited Type I Interferon Signaling in Monocytes:
Tweet media one
0
1
3
@CIR_AACR
Cancer Immunology Research
6 days
Cytotoxic Chemotherapy in a 3D Microfluidic Device Induces Dendritic Cell Recruitment and Trogocytosis of Cancer Cells:
Tweet media one
0
0
1
@CIR_AACR
Cancer Immunology Research
8 days
Cytoplasmic WEE1 Promotes Resistance to PD-1 Blockade Through Hyperactivation of the HSP90A/TCL1/AKT Signaling Axis in NANOGhigh Tumors:
Tweet media one
0
1
3
@CIR_AACR
Cancer Immunology Research
10 days
Naturally Arising Memory-Phenotype CD4+ T Lymphocytes Give Rise to Multiple Helper Subsets to Contribute to Tumor Immunity while Inhibiting GVHD:
Tweet media one
0
0
1
@CIR_AACR
Cancer Immunology Research
13 days
Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia:
Tweet media one
0
0
2
@CIR_AACR
Cancer Immunology Research
15 days
CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to Target:
Tweet media one
0
0
1
@CIR_AACR
Cancer Immunology Research
16 days
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma:
Tweet media one
0
0
3
@CIR_AACR
Cancer Immunology Research
18 days
Sign up to receive alerts directly to your inbox to keep up with the latest published issues:
Tweet media one
0
0
0
@CIR_AACR
Cancer Immunology Research
20 days
Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines:
Tweet media one
0
0
3
@CIR_AACR
Cancer Immunology Research
22 days
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development:
Tweet media one
0
0
1
@CIR_AACR
Cancer Immunology Research
24 days
Congratulations to Veronika Lutz, PhD, Christian Bauer, MD, and colleagues, recipients of the 2025 Cancer Immunology Research Award for Outstanding Journal Article. Learn more and read the article:
Tweet media one
0
0
0
@CIR_AACR
Cancer Immunology Research
24 days
Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome:
Tweet media one
0
0
6
@CIR_AACR
Cancer Immunology Research
28 days
What We're Reading: Article Recommendations from Our Deputy and Senior Editors
Tweet media one
0
0
1
@CIR_AACR
Cancer Immunology Research
29 days
Read the latest Editors' Pick: Selective STING Activation in Intratumoral Myeloid Cells via CCR2-Directed Antibody–Drug Conjugate TAK-500
@AACR
AACR
1 month
Editors’ Picks from the AACR journals highlight how tumor mutations mirror high-altitude oxygen adaptations, immune-based therapies, and environmental cancer risks, among other topics. Learn more on the #AACRBlog:
Tweet media one
0
0
1
@CIR_AACR
Cancer Immunology Research
1 month
Read the latest editors' picks: Stay up to date with the @AACR journals by signing up for alerts:
Tweet media one
0
0
0
@CIR_AACR
Cancer Immunology Research
1 month
PTP Inhibition Improves the Macrophage Antitumor Immune Response and the Efficacy of Chemo- and Radiotherapy:
Tweet media one
0
0
3
@CIR_AACR
Cancer Immunology Research
1 month
Antitumor CD4+ T Helper 1 Cells Target and Control the Outgrowth of Disseminated Cancer Cells:
Tweet media one
0
0
15